Anemia And Other Blood Disorder Drugs Market Growth Accelerates: Strategic Forecast Predicts $16.09 Billion by 2029

Anemia And Other Blood Disorder Drugs Market Growth Accelerates: Strategic Forecast Predicts $16.09 Billion by 2029Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Anemia And Other Blood Disorder Drugs Industry Market Size Be by 2025?
The market size for drugs treating anemia and other blood disorders has seen robust growth in the past few years. It is projected to expand from $11.61 billion in 2024 to $12.38 billion in 2025, with a compound annual growth rate (CAGR) of 6.6%. This growth in the historical period is due to reasons such as the prevalence of diseases, worldwide health initiatives, an aging populace, innovations in pharmaceuticals, and patient awareness.

What's the Long-Term Growth Forecast for the Anemia And Other Blood Disorder Drugs Market Size Through 2029?
Expectations predict robust growth in the size of the anemia and other blood disorder drugs market in the coming years. The expansion is forecasted to reach $16.09 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 6.8%. The anticipated growth during the forecast period is linked to factors such as emerging markets, worldwide demographics, and economic influences. Key trends likely to surface during this period include research and development, advancements in technology, biologics and targeted therapies, gene therapies, telemedicine and remote monitoring, orphan drug designations, as well as mergers and acquisitions.

View the full report here:
https://www.thebusinessresearchcompany.com/report/anemia-and-other-blood-disorder-drugs-global-market-report

What Are the Key Growth Drivers Fueling the Anemia And Other Blood Disorder Drugs Market Expansion?
The rise in anemia cases across the world serves as a potent propellant for the market. Factors such as unhealthy living conditions, altered food habits, and escalated levels of stress have contributed to this increase in anemia incidents globally. For example, the ailment was identified as the most common among older individuals (> 65 years), with prevalence rates nearing around 17%. The World Bank has indicated that anemia ranks as the 8th predominant ailment afflicting women and the younger demographic. The expanding prevalence of anemia propels the market for anemia and other blood disorder drugs.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2465&type=smp

What Are the Key Trends Driving Anemia And Other Blood Disorder Drugs Market Growth?
Firms operating within the anemia and other blood disorder drugs industry are partnering with government bodies to create and commercialize a distinct type of medication by distributing knowledge, technology, and expenses. Such alliances also benefit these firms in events of license termination and strict regulatory scenarios. For instance, in March 2023, Disc Medicine formed a partnership with the National Institutes of Health (NIH) and the National Heart, Lung, and Blood Institute (NHLBI) for the Phase 1/2 and Phase 2 clinical assessments of biopterin in Diamond-Blackfan Anemia (DBA) patients to deliver treatment to those adults with iron deficiency anemia. Under a cooperative research and development agreement (CRADA), these investigations will be performed and subsidized by the NIH.

How Is the Anemia And Other Blood Disorder Drugs Market Segmented?
The anemia and other blood disorder drugs market covered in this report is segmented -

1) By Type: Iron Deficiency Anemia, Chronic Kidney Disease Anemia, Sickle Cell Anemia, Aplastic Anemia
2) By Route of Administration: Oral, Injectable
3) By Distribution Channel: Hospitals Pharmacy, Online Pharmacy, Pharmacy

Subsegments:
1) By Iron Deficiency Anemia: Oral Iron Supplements, Injectable Iron Supplements, Iron Fortified Foods
2) By Chronic Kidney Disease Anemia: Erythropoiesis-Stimulating Agents (ESAs), Iron Supplements, Blood Transfusion
3) By Sickle Cell Anemia: Hydroxyurea, Blood Transfusions, Gene Therapy, Pain Management Drugs
4) By Aplastic Anemia: Immunosuppressive Therapy, Stem Cell Transplantation, Erythropoiesis-Stimulating Agents (ESAs)

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=2465&type=smp

Which Companies Are Leading the Charge in Anemia And Other Blood Disorder Drugs Market Innovation?
Major companies operating in the anemia and other blood disorder drugs market include Amgen Inc, GlaxoSmithKline plc, Akebia Therapeutics Inc., Bayer AG, Pfizer Inc, F. Hoffmann-La Roche Ltd., Merck Sharp & Dohme Corp., Novartis AG, Global Blood Therapeutics Inc., GlycoMimetics Inc., Eli Lilly and Company, FibroGen Inc., bluebird bio Inc., Acceleron Pharma Inc., AMAG Pharmaceuticals Inc., Pieris Pharmaceuticals Inc., Vifor Pharma Management Ltd., Sanofi S.A., Allergan U.S. Inc., Meda Consumer Healthcare Inc., AbbVie Inc., Johnson & Johnson, Daiichi Sankyo Company Limited, Galenica Ltd., Pharmacosmos A/S, Emmaus Medical Inc., Takeda Pharmaceutical Company Limited, Bristol-Myers Squibb Company, Merck & Co. Inc., Gilead Sciences Inc., Vertex Pharmaceuticals Incorporated, Alexion Pharmaceuticals Inc., Alnylam Pharmaceuticals Inc., uniQure N.V., Rubius Therapeutics Inc., BioMarin Pharmaceutical Inc., Grifols S.A., Orchard Therapeutics plc

Which Regions Are Leading the Global Anemia And Other Blood Disorder Drugs Market in Revenue?
North America was the largest region in the anemia and other blood disorder drugs market in 2023. Middle East is expected to be the fastest-growing region in the anemia and other blood disorder drugs market during the forecast period. The regions covered in the anemia and other blood disorder drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2465

"This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work."

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.